CDC Traveler-based Genomic Surveillance Program to Expand to Two New US International Airports in Miami and Chicago
This expanded funding will also bring the number of airports in the program to a total of nine active sites: Los Angeles, San Francisco, New York (JFK), Washington Dulles, Newark, Boston, Seattle, Miami, and Chicago.
- This expanded funding will also bring the number of airports in the program to a total of nine active sites: Los Angeles, San Francisco, New York (JFK), Washington Dulles, Newark, Boston, Seattle, Miami, and Chicago.
- Since its inception in September 2021, the TGS program has demonstrated its ability to serve as an early detection mechanism for new pathogens and fill gaps in global biosurveillance.
- In October 2023, the program expanded to cover a list of more than 30 viral and bacterial targets.
- “We are thrilled to have the opportunity to take the TGS program to the next level.